Rezultati pretraživanja
  1. 30. sij

    Shining the💡on alumni , who's experimental drug may have the potential to significantly reduce tumor size for patients with advanced lung & colorectal cancer. In a small, early-stage trial, 40% of patients saw a reduction in tumor size.

  2. 24. lip 2019.

    Congratulations to Joe Payne, Pad Chivukula @ArctusrusRX alumni for the expansion of its licensing deal for further discovery & development of therapeutics for 12 rare-disease targets. Read more:

  3. 24. lip 2019.

    Things are heating up for alumni company, who announced an expansion to their research collaboration to develop and for 12 rare disease targets. Read more:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.